PharmGKB is the pharmacogenomics database that encompasses clinical information such as dosage guidelines, drugs, gene-drug associations with actionable clinical potential and relationships between genotype and phenotype. It is a publicly available tool developed by Stanford University with funding from the NIH.

https://www.pharmgkb.org

A comprehensive list of FDA-approved drugs whose package leaflets contain pharmacogenomic information. This list includes medicines found in ConectGene reports.

http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm

ClinicalTrials.gov is a database of clinical trial results involving human participants. The database contains studies conducted around the world with public and private funds. It is a good source of information for clinical research into the effects of pharmacogenomics, both for drugs in development and for commercially available drugs.

https://clinicaltrials.gov

The NIH is the main US government agency responsible for biomedical and public health research.

http://www.nih.gov/about/discovery/technology/personalmed.htm

NIGMS is one of the institutes that make up the NIH and is part of the US Department of Health and Human Services. NIGMS supports basic research and training, leading advances in the areas of diagnosis, treatment and prevention. Together with other NIH institutes, NIGMS contributes by supporting the NIH Pharmacogenomics Research Network (PGRN).

https://www.nigms.nih.gov/education/Pages/factsheet-pharmacogenomics.aspx

An FDA database containing information on medicines.

https://www.accessdata.fda.gov/scripts/Cder/ob/index.cfm

Here you will find current articles on pharmacogenetics.

General studies:

Landmarks of Pharmacogenomics and some considerations for clinical practice

An-Economic-Evaluation-of-Pharmacogenomic-Testing (1)

Studies applied to psychiatry: